Maiden Pharmaceuticals

Haryana govt halts all drug production at factory linked to Gambia deaths

"Taking cognisance of this, the state government has ordered that all drug production at this unit be stopped with immediate effect," Vij told PTI over phone.

published on : 12th October 2022

Orders issued to halt drug manufacturing at Maiden Pharma's Sonipat unit: Haryana minister Anil Vij

The report of the samples of four cough syrups which had been recently sent to the Central Drugs Laboratory in Kolkata for examination was awaited.

published on : 12th October 2022

'Shocked, deeply saddened,' says Maiden pharma after WHO alert on its cough syrups links to child deaths in Gambia

The world body had also said syrups have been "potentially linked with acute kidney injuries and 66 deaths among children.”

published on : 8th October 2022

WHO alert on cough syrups 'alarming', there are missing links that need to be probed: Expert

Dr Gupta said the first death suspected to be due to the same reason was noted in July.

published on : 8th October 2022

Locals clueless about Haryana factory producing syrups blamed for Gambia children deaths

WHO recently warned that four "contaminated" cough syrups allegedly produced by Maiden Pharmaceuticals Ltd based in Sonipat could be behind the deaths of 66 Gambian children.

published on : 7th October 2022

India begins urgent investigation after WHO alert over four cough syrups linked to child deaths

The cough syrup by New Delhi-based Indian pharmaceutical company Maiden Pharmaceuticals is not sold in India but is being exported.

published on : 6th October 2022

WHO probing Indian cough syrup after 66 children die in Gambia

"Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants," the WHO said.

published on : 5th October 2022